You can find the annual or quarterly income statement of Milestone Pharmaceuticals Inc here for insights into the performance and operational efficiency of Milestone Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

Total revenue

--559.00K

--238.00K

--1.55M

--0.00

-100.00%0.00

--0.00

--1.00M

--3.50M

--1.50M

-100.00%0.00

----

--0.00

--15.00M

----

Revenue

--559.00K

--238.00K

--1.55M

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--1.00M

----

--1.50M

-100.00%0.00

----

--0.00

--15.00M

----

Cost of revenue

--32.00K

--14.00K

----

Operating expenses

108.99%26.19M

16.46%23.90M

51.48%18.80M

22.24%11.83M

28.83%12.53M

94.64%20.52M

-10.05%12.41M

-37.00%9.68M

-40.82%9.73M

-36.10%10.54M

-20.04%13.80M

-7.08%15.36M

-2.20%16.44M

17.48%16.50M

2.02%17.26M

15.81%16.53M

17.62%16.81M

11.54%14.05M

93.08%16.92M

18.11%14.27M

9.03%14.29M

-24.85%12.59M

-53.62%8.76M

-11.95%12.09M

-8.57%13.11M

53.32%16.76M

86.92%18.89M

137.25%13.72M

289.93%14.33M

156.87%10.93M

--10.11M

--5.79M

--3.68M

--4.25M

R&D expenses

-4.36%3.51M

-34.69%3.25M

37.85%5.52M

-2.09%3.94M

27.40%3.67M

34.29%4.98M

-26.54%4.00M

-40.13%4.02M

-66.60%2.88M

-63.86%3.71M

-48.46%5.45M

-31.60%6.72M

-19.10%8.62M

16.98%10.26M

-3.10%10.58M

0.96%9.83M

13.05%10.66M

2.01%8.77M

89.32%10.92M

18.29%9.73M

9.34%9.43M

-27.60%8.60M

-59.25%5.77M

-13.80%8.23M

-18.10%8.62M

52.89%11.87M

93.90%14.15M

144.06%9.54M

312.66%10.53M

151.21%7.76M

--7.30M

--3.91M

--2.55M

--3.09M

Depreciation, depletion, and amortization

103.57%57.00K

107.41%56.00K

30.77%34.00K

0.00%25.00K

7.69%28.00K

-3.57%27.00K

0.00%26.00K

4.17%25.00K

8.33%26.00K

55.56%28.00K

73.33%26.00K

-11.11%24.00K

0.00%24.00K

-21.74%18.00K

-34.78%15.00K

12.50%27.00K

4.35%24.00K

0.00%23.00K

-8.00%23.00K

4.35%24.00K

-8.00%23.00K

-4.17%23.00K

4.17%25.00K

155.56%23.00K

1150.00%25.00K

700.00%24.00K

1100.00%24.00K

200.00%9.00K

-33.33%2.00K

50.00%3.00K

--2.00K

--3.00K

--2.00K

Other operating expenses

----

--14.00K

----

Operating profit

-104.53%-25.63M

-15.30%-23.66M

-39.02%-17.26M

-22.24%-11.83M

-28.83%-12.53M

-94.64%-20.52M

10.05%-12.41M

37.00%-9.68M

40.82%-9.73M

31.98%-10.54M

-0.30%-13.80M

-2.20%-15.36M

2.20%-16.44M

-10.36%-15.50M

18.67%-13.76M

-5.30%-15.03M

-2460.39%-16.81M

-11.54%-14.05M

-93.08%-16.92M

-18.11%-14.27M

105.43%712.00K

24.85%-12.59M

53.62%-8.76M

11.95%-12.09M

8.57%-13.11M

-53.32%-16.76M

-86.92%-18.89M

-137.25%-13.72M

-289.93%-14.33M

-156.87%-10.93M

---10.11M

---5.79M

---3.68M

---4.25M

Net non-operating interest income (expenses)

Non-operating interest income

237.40%1.74M

148.49%1.73M

-7.85%833.00K

-19.07%874.00K

-56.49%516.00K

-29.88%697.00K

-13.58%904.00K

-3.57%1.08M

-2.23%1.19M

80.07%994.00K

79.73%1.05M

136.29%1.12M

667.72%1.21M

1280.00%552.00K

1611.76%582.00K

887.50%474.00K

172.41%158.00K

-50.00%40.00K

-64.58%34.00K

-46.07%48.00K

-53.97%58.00K

-80.72%80.00K

-84.08%96.00K

-89.16%89.00K

-81.25%126.00K

-17.00%415.00K

35.20%603.00K

865.88%821.00K

655.06%672.00K

455.56%500.00K

--446.00K

--85.00K

--89.00K

--90.00K

Non-operating interest expense

396.85%4.72M

342.25%4.13M

7.18%985.00K

7.09%967.00K

7.22%951.00K

7.22%935.00K

7.23%919.00K

7.37%903.00K

8.17%887.00K

--872.00K

--857.00K

--841.00K

--820.00K

----

Income before tax

-120.68%-28.61M

-25.55%-26.07M

-40.08%-17.41M

-25.49%-11.92M

-37.53%-12.97M

-99.20%-20.76M

8.69%-12.43M

37.01%-9.50M

41.23%-9.43M

30.29%-10.42M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.58%-14.22M

105.93%770.00K

23.43%-12.51M

52.62%-8.67M

7.04%-12.00M

5.00%-12.98M

-56.69%-16.34M

-89.31%-18.29M

-126.39%-12.90M

-280.88%-13.66M

-150.42%-10.43M

---9.66M

---5.70M

---3.59M

---4.17M

Income tax

----

---65.00K

---61.00K

---65.00K

---68.00K

----

--0.00

100.00%0.00

----

100.00%0.00

76.71%-17.00K

----

-100.00%0.00

-101.79%-1.00K

---73.00K

-300.00%-4.00K

37.50%22.00K

--56.00K

--0.00

--2.00K

--16.00K

Income after tax

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

Net income from continuous operations

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

Net income attributable to controlling interests

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

Net income attributable to common shareholders

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

Basic earnings per share

-5.62%-0.21

36.12%-0.20

11.99%-0.16

13.36%-0.12

-38.03%-0.20

-88.10%-0.39

40.98%-0.19

59.37%-0.14

62.13%-0.14

40.82%-0.21

-2.63%-0.32

-2.45%-0.35

5.11%-0.37

-5.21%-0.35

23.00%-0.31

-1.58%-0.34

-2230.79%-0.39

-9.32%-0.33

-35.44%-0.40

16.18%-0.34

103.51%0.02

54.44%-0.30

53.04%-0.30

23.21%-0.40

8.75%-0.53

-50.62%-0.67

-53.05%-0.63

-117.35%-0.52

-280.55%-0.58

-149.99%-0.44

---0.41

---0.24

---0.15

---0.18

Diluted earnings per share

-5.62%-0.21

36.12%-0.20

11.99%-0.16

13.36%-0.12

-38.03%-0.20

-88.10%-0.39

40.98%-0.19

59.37%-0.14

62.13%-0.14

40.82%-0.21

-2.63%-0.32

-2.45%-0.35

5.11%-0.37

-5.21%-0.35

23.00%-0.31

-1.58%-0.34

-2230.79%-0.39

-9.32%-0.33

-35.44%-0.40

16.18%-0.34

103.51%0.02

54.44%-0.30

53.04%-0.30

23.21%-0.40

8.75%-0.53

-50.62%-0.67

-53.05%-0.63

-117.35%-0.52

-280.55%-0.58

-149.99%-0.44

---0.41

---0.24

---0.15

---0.18

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Milestone Pharmaceuticals Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing MIST stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Milestone Pharmaceuticals Inc's revenue at year end?



Milestone Pharmaceuticals Inc reported 1.55M in revenue for fiscal year 2025, up from 1.55M in the previous year.

What was Milestone Pharmaceuticals Inc's net income for the year?



Milestone Pharmaceuticals Inc posted -63.06M in net income for fiscal year 2025.

How much net income did Milestone Pharmaceuticals Inc post in the last quarter?



Milestone Pharmaceuticals Inc reported -28.61M in net income for the latest quarter。

What was Milestone Pharmaceuticals Inc's annual operating profit?



Milestone Pharmaceuticals Inc's operating income was -62.48M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.